Top

Journal of Thrombosis and Thrombolysis

Published in:

01-04-2021 | COVID-19

Impact of COVID-19 on monitoring of therapeutic unfractionated heparin

Authors: Sarah K. Adie, Nicholas Farina

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2021

Excerpt

Anti-Xa and aPTT are prone to monitoring inaccuracies in patients with COVID-19 and severe illness.
Unexpected thrombosis or bleeding that does not correlate with anti-Xa or aPTT levels may indicate level inaccuracies
More research is needed on the monitoring assay to optimize UFH dose titration in COVID-19 patients

…

Bikdeli B, Madhavan MV, Jimenez D et al (2020) COVID-19 and thrombotic and thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 75:2950–2973CrossRef

Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. https://doi.org/10.1016/j.thromres.2020.04.013CrossRefPubMedPubMedCentral

Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 18:844–847CrossRef

Tang N, Bai H, Chen X, Gong J, Li D, Sun Z (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 18:1094–1099CrossRef

Artim-Esen B, Pericleous C, Mackie I et al (2015) Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays. Arthritis Res Ther 1:47CrossRef

Zhang Y, Xiao M, Zhang S et al (2020) Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med 382:e38CrossRef

Vandiver JW, Vondracek TG (2012) Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin. Pharmacotherapy 32(6):546–558CrossRef

Spiezia L, Boscolo A, Poletta F et al (2020) COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. 120:998CrossRef

Borges AH, O'Connor JL, Phillips AN et al (2014) Factors associated with D-dimer levels in HIV-infected individuals. PLoS ONE 9:e90978CrossRef

10.

Ramacciotti E, Agati LB, Aguiar VCR et al (2019) Zika and Chikungunya virus and risk for venous thromboembolism. Clin Appl Thromb Hemost 25:1076029618821184PubMedPubMedCentral

11.

Smither SJ, O'Brien LM, Eastaugh L et al (2019) Haemostatic changes in five patients infected with Ebola virus. Viruses 11:647CrossRef

Title: Impact of COVID-19 on monitoring of therapeutic unfractionated heparin
Authors: Sarah K. Adie
Nicholas Farina
Publication date: 01-04-2021
Publisher: Springer US
Keywords: COVID-19
Heparin
Published in: Journal of Thrombosis and Thrombolysis / Issue 3/2021
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-020-02250-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Impact of COVID-19 on monitoring of therapeutic unfractionated heparin

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2021

Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate

Evaluation of relationship between KEAP1 gene and genetic susceptibility of deep vein thrombosis after orthopedic surgery in Han Chinese population

Effects of clinical depression on left ventricular dysfunction in patients with acute coronary syndrome

Correction to: The perplexity of catheter-directed thrombolysis for deep venous thrombosis: the approaches play an important role

Utility of the 4Ts score in excluding heparin-induced thrombocytopenia in lung transplant recipients

Decreased pulmonary artery distensibility as a marker for severity in acute pulmonary embolism patients undergoing ECG-gated CTPA

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page